DongKook Pharmaceutical (Korea) Performance
| 086450 Stock | KRW 15,540 10.00 0.06% |
The firm shows a Beta (market volatility) of -0.27, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning DongKook Pharmaceutical are expected to decrease at a much lower rate. During the bear market, DongKook Pharmaceutical is likely to outperform the market. At this point, DongKook Pharmaceutical has a negative expected return of -0.0359%. Please make sure to confirm DongKook Pharmaceutical's jensen alpha, treynor ratio, and the relationship between the standard deviation and total risk alpha , to decide if DongKook Pharmaceutical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days DongKook Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, DongKook Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -43.5 B |
DongKook |
DongKook Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 1,600,622 in DongKook Pharmaceutical Co on December 5, 2024 and sell it today you would lose (46,622) from holding DongKook Pharmaceutical Co or give up 2.91% of portfolio value over 90 days. DongKook Pharmaceutical Co is generating negative expected returns and assumes 1.8587% volatility on return distribution over the 90 days horizon. Simply put, 16% of stocks are less volatile than DongKook, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
DongKook Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DongKook Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as DongKook Pharmaceutical Co, and traders can use it to determine the average amount a DongKook Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0193
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 086450 |
Estimated Market Risk
| 1.86 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average DongKook Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DongKook Pharmaceutical by adding DongKook Pharmaceutical to a well-diversified portfolio.
DongKook Pharmaceutical Fundamentals Growth
DongKook Stock prices reflect investors' perceptions of the future prospects and financial health of DongKook Pharmaceutical, and DongKook Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DongKook Stock performance.
| Return On Equity | 12.72 | |||
| Return On Asset | 0.0608 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 1.08 T | |||
| Shares Outstanding | 8.79 M | |||
| Price To Earning | 19.52 X | |||
| Price To Sales | 0.24 X | |||
| Revenue | 594.19 B | |||
| EBITDA | 83.48 B | |||
| Cash And Equivalents | 85.44 B | |||
| Total Debt | 13.69 B | |||
| Debt To Equity | 0.15 % | |||
| Book Value Per Share | 23,358 X | |||
| Cash Flow From Operations | 44.65 B | |||
| Total Asset | 750.08 B | |||
| Retained Earnings | 172.22 B | |||
| Current Asset | 203.59 B | |||
| Current Liabilities | 64.06 B | |||
About DongKook Pharmaceutical Performance
By analyzing DongKook Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into DongKook Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if DongKook Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DongKook Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea. DongKook Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about DongKook Pharmaceutical performance evaluation
Checking the ongoing alerts about DongKook Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for DongKook Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DongKook Pharmaceutical generated a negative expected return over the last 90 days | |
| About 47.0% of the company shares are owned by insiders or employees |
- Analyzing DongKook Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DongKook Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining DongKook Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DongKook Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DongKook Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DongKook Pharmaceutical's stock. These opinions can provide insight into DongKook Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for DongKook Stock analysis
When running DongKook Pharmaceutical's price analysis, check to measure DongKook Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DongKook Pharmaceutical is operating at the current time. Most of DongKook Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of DongKook Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DongKook Pharmaceutical's price. Additionally, you may evaluate how the addition of DongKook Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |